Home ⟩ Insights

Insights

fda

3 min read • September 24, 2024

DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling

5 min read • August 28, 2024

Cannabis And Psychedelics Industries: Summer’s Over, Where Are We?

2 min read • August 22, 2024

Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Company

2 min read • August 2, 2024

Cannabis Pharmaceuticals: Company With Ties To Groundbreaking Medical Developments Pursues Cannabinoid-Based Medicines

3 min read • July 24, 2024

Harris Vs. Trump: Will Cannabis Rescheduling Survive Biden’s Exit? Analyst On Potential GOP Victory

3 min read • July 11, 2024

Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US

3 min read • June 18, 2024

What Is The Trump Factor? Justice Dept’s Impact On Cannabis Rescheduling, Stocks And Investments

3 min read • June 13, 2024

Over 400 Physicians And Medical Experts Demand U.S. Gov Fully Deschedule Cannabis, Citing Insufficiency Of Rescheduling

2 min read • June 11, 2024

DEA Vs. Biden, FDA & Health Agency Over Cannabis Rescheduling: What’s Up With That?

3 min read • May 31, 2024

From Prohibition To Protection: Could Marijuana’s Reclassification Unleash A Surge In Trademark Filings?

5 min read • May 28, 2024

California’s Famous Cannabis Goes To Europe: Rescheduling Drives Demand For De-Risked, Pest-Free, Low-Cost Plants

4 min read • May 23, 2024

How Will Cannabis Rescheduling Impact Commercial Real Estate

Latest Headlines

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

5 min read • August 31, 2026

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

6 min read • August 31, 2026

USCR Urges Congress to Keep the Hemp Loophole Closed

4 min read • August 28, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

3 min read • August 28, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

5 min read • August 27, 2026

Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns

2 min read • August 27, 2026

IM Cannabis Implements 30-for-1 Reverse Stock Split as It Fights to Maintain Nasdaq Listing

4 min read • August 26, 2026

Four Things Nobody Told You About the DEA Cannabis Hearings — But You Probably Wanted to Ask

3 min read • August 26, 2026

Financial Times: Germany’s Cannabis Imports Surge Sixfold, Regulatory Pressure Mounts

3 min read • August 25, 2026

Comply With What? Hemp Ban Nears; the FDA Leaves Industry Waiting for Answers

4 min read • August 25, 2026

Curaleaf vs. Aurora: The $4 Cannabis Takeover Fight Gets Hostile — Literally

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.